Jefferies Starts Hansen Natural (HANS) at Buy, Sees 19% Upside
Tweet Send to a Friend
Get Alerts HANS Hot Sheet
Price: $95.38 --0%
Rating Summary:
0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Rating Summary:
0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Trade HANS Now!
Jefferies initiates coverage on Hansen Natural (NASDAQ: HANS) with a Buy rating and $85 price target, suggesting 19% upside.
The firm states, "We are buyers of HANS share for three reasons: 1) Monster Energy brand winning market share in fastest growing beverage category, 2) we believe Monster is in just the 2nd inning of international growth opportunity and 3) valuation does no fully reflect HANS's elite fundamentals - especially as an extremely rare large-cap consumer growth story."
For more ratings news on Hansen Natural click here and for the rating history of Hansen Natural click here.
Shares of Hansen Natural closed at $71.65 yesterday, with a 52 week range of $37.28-$71.96.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The firm states, "We are buyers of HANS share for three reasons: 1) Monster Energy brand winning market share in fastest growing beverage category, 2) we believe Monster is in just the 2nd inning of international growth opportunity and 3) valuation does no fully reflect HANS's elite fundamentals - especially as an extremely rare large-cap consumer growth story."
For more ratings news on Hansen Natural click here and for the rating history of Hansen Natural click here.
Shares of Hansen Natural closed at $71.65 yesterday, with a 52 week range of $37.28-$71.96.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Guggenheim Starts Biota Pharmaceuticals (BOTA) at Buy
- Topeka Capital Starts Diodes (DIOD) at Buy
- Topeka Capital Starts CEVA Inc. (CEVA) at Buy
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
Jefferies & CoLogin with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

